» Authors » Luckson Mathieu

Luckson Mathieu

Explore the profile of Luckson Mathieu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 237
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mathieu L, Shah S, Pai-Scherf L, Larkins E, Vallejo J, Li X, et al.
Oncologist . 2021 Mar; 26(5):433-438. PMID: 33687763
The U.S. Food and Drug Administration (FDA) granted approval to atezolizumab and durvalumab in March of 2019 and 2020, respectively, for use in combination with chemotherapy for first-line treatment of...
2.
Odogwu L, Mathieu L, Blumenthal G, Larkins E, Goldberg K, Griffin N, et al.
Oncologist . 2018 Feb; 23(6):740-745. PMID: 29438093
Implications For Practice: The approvals of dabrafenib and trametinib, administered concurrently, provide a new regimen for the treatment of a rare subset of non-small cell lung cancer (NSCLC) and demonstrate...
3.
Odogwu L, Mathieu L, Goldberg K, Blumenthal G, Larkins E, Fiero M, et al.
Oncologist . 2017 Dec; 23(3):353-359. PMID: 29242281
Implications For Practice: Osimertinib administered to metastatic non-small cell lung cancer (NSCLC) patients harboring an EGFR T790M mutation, who have progressed on or following EGFR TKI therapy, demonstrated a substantial...
4.
Kanarek N, Hooker C, Mathieu L, Tsai H, Rudin C, Herman J, et al.
Am J Med . 2014 Feb; 127(5):443-9. PMID: 24486286
Background: "Rush to surgery" among patients with worse symptoms, delays related to morbidity, and inclusion of patients with advanced disease in study populations have produced a mixed picture of importance...
5.
Agrawal M, Kanakry J, Arnold C, Suzman D, Mathieu L, Kasamon Y, et al.
Ann Hematol . 2013 Nov; 93(7):1245-6. PMID: 24232305
No abstract available.